Examples of using Trough concentrations in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
The target for trough concentrations was 10-20 ng/mL.
Multiple doses of ambrisentan resulted in slight increases in digoxin AUC0-last and trough concentrations, and a 29% increase in digoxin Cmax.
Nintedanib trough concentrations remained stable for more than one year.
At Month 1, 4, and 6 post-transplant, the mean(range) trough concentrations of belatacept were 22.7 11.1-45.2.
Trough concentrations of spinosad doubled monthly up to month 5.
At apparent steady-state with TREVICTA, the trough concentrations were similar among normal, overweight, and obese subjects.
At steady state, fulvestrant plasma concentrations are maintained within a relatively narrow range with approximately 2-to 3-fold difference between maximum and trough concentrations.
The mean serum steady state trough concentrations ranged from 1.6 to 2.1 mcg/ ml at weeks 12, 24, and 48.
Patients receiving VIRACEPT BID(n=10)achieved nelfinavir Cmax of 4.0± 0.8 µg/ml and morning and evening trough concentrations of 2.2± 1.3 µg/ml and 0.7± 0.4 µg/ml, respectively.
Sirolimus trough concentrations should be monitored at least 3 to 4 days after a loading doses.
Most patients who received 2 mg of Rapamune 4hours after ciclosporin had whole blood trough concentrations of sirolimus within the 4 to 12 ng/mL target range expressed as chromatographic assay values.
Everolimus trough concentrations should be assessed approximately 2 weeks after the addition of a moderate CYP3A4 or PgP inhibitor.
Patients receiving VIRACEPT TID(n=11) achieved nelfinavir peak plasma concentrations(Cmax)of 3.0 1.6 µg/ml and morning and evening trough concentrations of 1.4 0.6 µg/ml and 1.0 0.5 µg/ml, respectively.
The mean(±SD) serum adalimumab trough concentrations achieved at Week 4 were 15.7±6.6g/mL for patients≥ 40 kg(160/80 mg) and 10.6±6.1g/mL for patients< 40 kg 80/40 mg.
A loading dose should be considered in addition to a new maintenance dose when itis necessary to considerably increase sirolimus trough concentrations: Rapamune loading dose 3 x new maintenance dose- current maintenance dose.
Therefore trough concentrations that fall in the upper part of the usual therapeutic range should be targetted and careful attention should be paid to clinical signs and symptoms, laboratory parameters and tissue biopsies.
Following repeat subcutaneous administration of140 mg every 2 weeks, the 12 week trough concentrations were 147% higher and 70% lower in patients of 69 kg and 93 kg respectively, than that of the typical 81 kg subject.
In a population pharmacokinetic assessment of Phase I, II and III clinical trials in metastatic breast cancer, the estimated mean AUC was 578 mg day/ L andthe estimated mean peak and trough concentrations were 110 mg/ L and 66 mg/ L, respectively.
The difference between morning and afternoon or evening trough concentrations for the TID and BID regimens was also observed in healthy volunteers who were dosed at precise 8- or 12-hour intervals.
The trough concentration of belatacept was consistently maintained up to 5 years post-transplant.
Target whole blood trough concentration recommendations Dosing should primarily be based on clinical assessments of rejection and tolerability in each individual patient.
It is recommended that a trough concentration be taken 1 or 2 weeks after switching formulations or tablet strength to confirm that the trough concentration is within the recommended target range.
The week 12 trough concentration following repeat subcutaneous administration of 140 mg every 2 weeks were in patients of 69 kg and 93 kg, 147% higher and 70% lower, respectively, than the trough concentration of the typical 81 kg subject.
The mean steady state plasma amprenavir trough concentration(Cmin) was 2.12(1.77-2.54) µg/ ml and AUC0-tau was 39.6(34.5- 45.3) h*µg/ ml.
Suggested ciclosporin trough concentration ranges for the first 2-3 months after transplantation are 150-400 ng/mL(monoclonal assay or equivalent technique) see section 4.5.
CANCIDAS reduced the trough concentration of tacrolimus by 26% in healthy adult volunteers.
The mean steady-state trough concentration prior to the morning dose was 5.5± 4.0 μ g/ ml.